Cardinal Health, Inc. (NYSE:CAH) Shares Bought by IFP Advisors Inc

IFP Advisors Inc lifted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 34.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,701 shares of the company’s stock after acquiring an additional 690 shares during the period. IFP Advisors Inc’s holdings in Cardinal Health were worth $319,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. HealthInvest Partners AB grew its holdings in Cardinal Health by 11.6% during the 4th quarter. HealthInvest Partners AB now owns 30,680 shares of the company’s stock valued at $3,618,000 after purchasing an additional 3,180 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its holdings in Cardinal Health by 2.1% during the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 52,517 shares of the company’s stock valued at $6,211,000 after purchasing an additional 1,100 shares in the last quarter. Sigma Planning Corp grew its holdings in Cardinal Health by 3.6% during the 4th quarter. Sigma Planning Corp now owns 11,844 shares of the company’s stock valued at $1,401,000 after purchasing an additional 413 shares in the last quarter. Transcend Capital Advisors LLC grew its holdings in Cardinal Health by 3.6% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company’s stock valued at $323,000 after purchasing an additional 96 shares in the last quarter. Finally, Handelsbanken Fonder AB grew its holdings in Cardinal Health by 11.6% during the 4th quarter. Handelsbanken Fonder AB now owns 39,783 shares of the company’s stock valued at $4,705,000 after purchasing an additional 4,140 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Cardinal Health stock opened at $129.71 on Friday. The firm’s 50-day moving average is $124.74 and its 200-day moving average is $118.16. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $132.84. The company has a market cap of $31.33 billion, a P/E ratio of 24.20, a PEG ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.56%. Cardinal Health’s payout ratio is currently 37.69%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on CAH shares. Argus set a $148.00 price target on shares of Cardinal Health in a report on Tuesday, February 4th. Jefferies Financial Group raised shares of Cardinal Health from a “hold” rating to a “buy” rating and raised their price target for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. UBS Group raised their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a report on Monday, November 4th. Barclays increased their price objective on shares of Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Finally, Citigroup increased their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.